why choose us

Clinical Trials Search

Showing 18,090 of 132,963 result(s)
Humoral and Cellular Immunity Against SARS-COV-2 Vaccine in HIV-infected Patients Immunosuppressed

Status: Active, not recruiting

Condition: SARS-CoV-2 RNA Vaccines
HIV Infection

Interventions: Biological: SARS-CoV-2 Vaccine
Analyse humoral and cellular response to SARS-CoV-2 Vaccine.

Date: 2022-11-21

Circulating Tumor Cells Screen for Breast Cancer

Status: Active, not recruiting

Condition: Breast Neoplasm
Neoplastic Cells, Circulating

Interventions: Diagnostic Test: Peripheral blood sampling for circulating tumor cells
Patients had 3-4 ml of venous blood drawn on day 1 after admission, ethyle

Date: 2022-11-21

HRR as a Novel Biomarker in Sjögren's Syndrome

Status: Completed

Condition: Sjögren's Syndrome

Interventions: Other: blood sample analysis
All subjects went through a routine ocular examination, and the peripheral venous blood samples were collected and a

Date: 2022-11-21

A Clinical Performance of Two Soft Toric Contact Lenses

Status: Completed

Condition: Astigmatism

Interventions: Interventional

Date: 2022-11-21

Interest of Instantaneous Fluctuations of Pupillary Diameter for Pain Evaluation in Intensive Care Sedated Patients.

Status: Completed

Condition: Intubation Complication

Interventions: Other: Datas analysed by medical records
Datas analysed by medical records : pupillary parameters: pupillary diameter and pupillary diameter vari

Date: 2022-11-21

Avicena LVDP Validation Study

Status: Completed

Condition: Heart Failure

Interventions: Interventional

Date: 2022-11-21

Association of Herpesvirus and Periodontitis

Status: Completed

Condition: Periodontitis

Interventions: Genetic: Sampe collection
Unstimulated crevicular fluid samples are collected using two sized 35 paper cones per subject, both used in the sampli

Date: 2022-11-21

A Study of Effect of Selpercatinib (LY3527723) on Corrected QT (QTc) Interval in Healthy Participants

Status: Completed

Condition: Healthy

Interventions: Interventional

Date: 2022-11-21

Ramucirumab Plus Pembrolizumab vs Usual Care for Treatment of Stage IV or Recurrent Non-Small Cell Lung Cancer Following Immunotherapy, Pragmatica-Lung Study

Status: Completed

Condition: Recurrent Lung Non-Small Cell Carcinoma

Interventions: Receive standard of care chemotherapy

Date: 2022-11-21